Celldex Therapeutics (CLDX) PT Bumped to $34 at Cowen Amid ReACT Study
Tweet Send to a Friend
Cowen analyst Boris Peaker reiterated an Outperform rating and bumped his price target on Celldex Therapeutics (NASDAQ: CLDX) to $34.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
